Impella Versus VA-ECMO for Patients with Cardiogenic Shock: Preliminary Cost-Effectiveness Analysis in the Italian Context.

The analysis considered direct healthcare costs and excluded patients’ productivity losses in the post-implant period and out-of-pocket costs related to formal or informal care, which may be significant for the category of patients under investigation.

also in 13,097 other papers